{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:33:28Z","timestamp":1790775208209,"version":"4.1.0"},"reference-count":21,"publisher":"The Korean Association for the Study of the Liver","issue":"2","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Health Bureau of HKSAR","award":["20210891"],"award-info":[{"award-number":["20210891"]}]}],"content-domain":{"domain":["e-cmh.org"],"crossmark-restriction":true},"short-container-title":["Clin Mol Hepatol"],"published-print":{"date-parts":[[2026,4,1]]},"abstract":"<jats:p>Background\/Aims: Previous studies have identified a substantial degree of agreement between the non-alcoholic fatty liver disease (NAFLD) and metabolic dysfunction-associated steatotic liver disease (MASLD) populations, but the same notion may not apply to normal-weight patients with a lower cardiometabolic risk burden. This study aims to investigate the cardiometabolic risk factor (CMRF) distributions between normal-weight and overweight\/obese MASLD, the agreement between historical NAFLD and MASLD, and to compare the risk of liver-related events (LREs) and all-cause mortality in normal-weight versus overweight or obese MASLD.Methods: This study included participants with steatotic liver disease (SLD) from five cohorts in China (Hong Kong), South Korea, and the United States. Participants were recruited from settings including both hospitals and communities. Individuals were classified into normal-weight and overweight\/obese groups.Results: This study included 33,793 participants with SLD from five cohorts, of whom 20,893 and 20,701 patients met the diagnosis of NAFLD and MASLD, respectively. Normal-weight patients with NAFLD demonstrated a lower CMRF distribution compared to those with overweight\/obese NAFLD. In the community-based cohorts, the proportions with 0 CMRF ranged from 9.0 to 26.7% among normal-weight NAFLD patients, representing the discrepancy between MASLD and NAFLD definitions. Compared with the overweight\/obese MASLD, the normalweight MASLD had increased all-cause mortality (normal-weight vs. overweight\/obese, 23.44 and 13.80 per 1,000 person-years; &lt;i&gt;P&lt;\/i&gt;&lt;0.001) but not LREs (2.81 and 2.59 per 1,000 person-years; &lt;i&gt;P&lt;\/i&gt;=0.54) in the Hong Kong Clinical Data Analysis and Reporting System cohort.Conclusions: Normal-weight individuals with NAFLD demonstrated a lower distribution of CMRFs, resulting in the incomplete agreement between historical NAFLD and MASLD.<\/jats:p>","DOI":"10.3350\/cmh.2025.0851","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T04:41:11Z","timestamp":1765514471000},"page":"646-660","update-policy":"https:\/\/doi.org\/10.3350\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Normal-weight metabolic dysfunction-associated steatotic liver disease: reclassification, characteristics, and adverse liver outcomes across diverse populations"],"prefix":"10.3350","volume":"32","author":[{"given":"Sherlot Juan","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen Laureal","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent Wai-Sun","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ae Jeong","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace Lai-Hung","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy Che-To","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2875-6139","authenticated-orcid":true,"given":"Dae Won","family":"Jun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1819-2464","authenticated-orcid":true,"given":"Terry Cheuk-Fung","family":"Yip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1902","reference":[{"key":"ref1","first-page":"1966","volume-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","author":"Rinella","year":"2023"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.07.021"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.08.021"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.08.026"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2024.0631"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-300342"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1159\/000539371"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.01.042"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2018.04.043"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/s2468-1253(20)30357-5"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.05.042"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/s2468-1253(20)30077-7"},{"key":"ref13","first-page":"848","volume-title":"Epidemiology of lean\/non-obese nonalcoholic fatty liver disease in China: a systematic review and meta-analysis","author":"Zhang","year":"2023"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/nqaa258"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/hep.0000000000000329"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2021.12.034"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.04.002"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-317334"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2012.09.025"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-022-00635-5"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3390\/cimb45110570"}],"container-title":["Clinical and Molecular Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/e-cmh.org\/upload\/pdf\/cmh-2025-0851.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/e-cmh.org\/journal\/view.php?doi=10.3350\/cmh.2025.0851","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/e-cmh.org\/upload\/pdf\/cmh-2025-0851.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T07:57:54Z","timestamp":1776671874000},"score":1,"resource":{"primary":{"URL":"http:\/\/e-cmh.org\/journal\/view.php?doi=10.3350\/cmh.2025.0851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"URL":"https:\/\/doi.org\/10.3350\/cmh.2025.0851","relation":{},"ISSN":["2287-2728","2287-285X"],"issn-type":[{"value":"2287-2728","type":"print"},{"value":"2287-285X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"assertion":[{"value":"2025-07-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-09","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-12","order":2,"name":"published","label":"Published online","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-01","order":3,"name":"published","label":"Print publication","group":{"name":"publication_history","label":"Publication History"}}]}}